Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-KGAA-436395/news/Merck-FDA-Approves-BAVENCIO-avelumab-Plus-INLYTA-axitinib-Combination-for-Patients-with-Ad-28597152/?utm_source=whatsapp&utm_medium=social&utm_campaign=share